Baidu
map

血液科指南

订阅

MedSci主页 / 所有栏目 / 血液科指南

血液净化急诊临床应用专家共识

2016-01-01 国内急诊/重症相关专家小组（统称） 中华急诊医学杂志.2017,26(1):24-36.

血液净化

国内部分专家基于国内外临床证据，结合临床实践经验，制定《血液净化急诊临床应用专家共识》。

中文标题：

血液净化急诊临床应用专家共识

发布机构：

国内急诊/重症相关专家小组（统称）

发布日期：

2016-01-01

简要介绍：

血液净化（ｂｌｏｏｄｐｕｒｉｆｉｃａｔｉｏｎ） 技术指各种连续或间断清除体内过多水分、溶质方法的总称，该技术是在肾脏替代治疗技术的基础上逐步发展而来。目前，血液净化技术在急诊、危重症领域得到广泛的应用，已经成为了急诊、ＩＣＵ治疗急危重症患者的重要技术。为进一步规范血液净化治疗技术在急诊的应用，国内部分专家基于国内外临床证据，结合临床实践经验，制定《血液净化急诊临床应用专家共识》. 拓展指南：与血液净化相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=血液净化急诊临床应用专家共识)] GetToolGuiderByIdResponse(projectId=1, id=a4b6c1c0013a83cf, title=血液净化急诊临床应用专家共识, enTitle=, guiderFrom=中华急诊医学杂志.2017,26(1):24-36., authorId=null, author=, summary=国内部分专家基于国内外临床证据，结合临床实践经验，制定《血液净化急诊临床应用专家共识》。, cover=, journalId=null, articlesId=null, associationId=780, associationName=国内急诊/重症相关专家小组（统称）, associationIntro=null, copyright=0, guiderPublishedTime=Fri Jan 01 00:00:00 CST 2016, originalUrl=, linkOutUrl=, content=血液净化（ｂｌｏｏｄｐｕｒｉｆｉｃａｔｉｏｎ） 技术指各种连续或间断清除体内过多水分、溶质方法的总称，该技术是在肾脏替代治疗技术的基础上逐步发展而来。目前，血液净化技术在急诊、危重症领域得到广泛的应用，已经成为了急诊、ＩＣＵ治疗急危重症患者的重要技术。为进一步规范血液净化治疗技术在急诊的应用，国内部分专家基于国内外临床证据，结合临床实践经验，制定《血液净化急诊临床应用专家共识》. 拓展指南：<strong>与<font color=red>血液净化</font>相关指南：</strong><br><ul><li><a href="//www.sandwebs.com/guideline/show_article.do?id=73a191c00128e7ab" title="2016 非生物型人工肝/血液净化治疗儿童急性肝衰竭技术规范" target=_blank>2016 非生物型人工肝/血液净化治疗儿童急性肝衰竭技术规范</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=c48521c0009308e7" title="2012 连续血液净化治疗儿童严重脓毒症的专家共识" target=_blank>2012 连续血液净化治疗儿童严重脓毒症的专家共识</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=dc32f1c000ea90d6" title="血液净化标准操作规程2010" target=_blank>血液净化标准操作规程2010</a></li> 更多信息请点击：<a href="//www.sandwebs.com/guideline/list.do?q=%E8%A1%80%E6%B6%B2%E5%87%80%E5%8C%96" target=_blank>有关血液净化更多指南</a></ul>, tagList=[TagDto(tagId=38508, tagName=血液净化)], categoryList=[CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7372, appHits=375, showAppHits=4, pcHits=5196, showPcHits=2747, likes=166, shares=27, comments=7, approvalStatus=1, publishedTime=Tue Jan 10 13:40:25 CST 2017, publishedTimeString=2016-01-01, pcVisible=1, appVisible=1, editorId=5295955, editor=yingzheng.gu, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=yingzheng.gu, createdTime=Tue Jan 10 13:40:25 CST 2017, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 17:16:17 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=血液净化急诊临床应用专家共识)])
血液净化急诊临床应用专家共识
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=882477, encodeId=8d838824e766, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8332512312, createdName=124c08ddm99暂无昵称, createdTime=Thu Sep 03 14:17:25 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882476, encodeId=2d6f8824e6ff, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8332512312, createdName=124c08ddm99暂无昵称, createdTime=Thu Sep 03 14:17:18 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882475, encodeId=0ade8824e5a5, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8332512312, createdName=124c08ddm99暂无昵称, createdTime=Thu Sep 03 14:17:14 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882474, encodeId=91b78824e46a, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8332512312, createdName=124c08ddm99暂无昵称, createdTime=Thu Sep 03 14:16:57 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169350, encodeId=742a16935075, content=学习啦，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/31/60fc0213ae09a3dbbba19993663ef4db.jpg, createdBy=33c31971480, createdName=1e160a78m83(暂无匿称), createdTime=Tue Jan 10 15:26:59 CST 2017, time=2017-01-10, status=1, ipAttribution=)]
    2020-09-03 124c08ddm99暂无昵称

    好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=882477, encodeId=8d838824e766, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8332512312, createdName=124c08ddm99暂无昵称, createdTime=Thu Sep 03 14:17:25 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882476, encodeId=2d6f8824e6ff, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8332512312, createdName=124c08ddm99暂无昵称, createdTime=Thu Sep 03 14:17:18 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882475, encodeId=0ade8824e5a5, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8332512312, createdName=124c08ddm99暂无昵称, createdTime=Thu Sep 03 14:17:14 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882474, encodeId=91b78824e46a, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8332512312, createdName=124c08ddm99暂无昵称, createdTime=Thu Sep 03 14:16:57 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169350, encodeId=742a16935075, content=学习啦，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/31/60fc0213ae09a3dbbba19993663ef4db.jpg, createdBy=33c31971480, createdName=1e160a78m83(暂无匿称), createdTime=Tue Jan 10 15:26:59 CST 2017, time=2017-01-10, status=1, ipAttribution=)]
    2020-09-03 124c08ddm99暂无昵称

    好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=882477, encodeId=8d838824e766, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8332512312, createdName=124c08ddm99暂无昵称, createdTime=Thu Sep 03 14:17:25 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882476, encodeId=2d6f8824e6ff, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8332512312, createdName=124c08ddm99暂无昵称, createdTime=Thu Sep 03 14:17:18 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882475, encodeId=0ade8824e5a5, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8332512312, createdName=124c08ddm99暂无昵称, createdTime=Thu Sep 03 14:17:14 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882474, encodeId=91b78824e46a, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8332512312, createdName=124c08ddm99暂无昵称, createdTime=Thu Sep 03 14:16:57 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169350, encodeId=742a16935075, content=学习啦，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/31/60fc0213ae09a3dbbba19993663ef4db.jpg, createdBy=33c31971480, createdName=1e160a78m83(暂无匿称), createdTime=Tue Jan 10 15:26:59 CST 2017, time=2017-01-10, status=1, ipAttribution=)]
    2020-09-03 124c08ddm99暂无昵称

    好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=882477, encodeId=8d838824e766, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8332512312, createdName=124c08ddm99暂无昵称, createdTime=Thu Sep 03 14:17:25 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882476, encodeId=2d6f8824e6ff, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8332512312, createdName=124c08ddm99暂无昵称, createdTime=Thu Sep 03 14:17:18 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882475, encodeId=0ade8824e5a5, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8332512312, createdName=124c08ddm99暂无昵称, createdTime=Thu Sep 03 14:17:14 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882474, encodeId=91b78824e46a, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8332512312, createdName=124c08ddm99暂无昵称, createdTime=Thu Sep 03 14:16:57 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169350, encodeId=742a16935075, content=学习啦，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/31/60fc0213ae09a3dbbba19993663ef4db.jpg, createdBy=33c31971480, createdName=1e160a78m83(暂无匿称), createdTime=Tue Jan 10 15:26:59 CST 2017, time=2017-01-10, status=1, ipAttribution=)]
    2020-09-03 124c08ddm99暂无昵称

    好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=882477, encodeId=8d838824e766, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8332512312, createdName=124c08ddm99暂无昵称, createdTime=Thu Sep 03 14:17:25 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882476, encodeId=2d6f8824e6ff, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8332512312, createdName=124c08ddm99暂无昵称, createdTime=Thu Sep 03 14:17:18 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882475, encodeId=0ade8824e5a5, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8332512312, createdName=124c08ddm99暂无昵称, createdTime=Thu Sep 03 14:17:14 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882474, encodeId=91b78824e46a, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8332512312, createdName=124c08ddm99暂无昵称, createdTime=Thu Sep 03 14:16:57 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169350, encodeId=742a16935075, content=学习啦，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/31/60fc0213ae09a3dbbba19993663ef4db.jpg, createdBy=33c31971480, createdName=1e160a78m83(暂无匿称), createdTime=Tue Jan 10 15:26:59 CST 2017, time=2017-01-10, status=1, ipAttribution=)]
    2017-01-10 1e160a78m83(暂无匿称)

    学习啦，谢谢分享

    0

相关指南

2016 非生物型人工肝/血液净化治疗儿童急性肝衰竭技术规范

中国儿科相关医学专家组（统称） · 2016-09-25

Baidu
map
Baidu
map
Baidu
map